The purpose of the NCUK Barriers Survey was to consolidate and add to previous national and global neuroendocrine cancer (NC)* patient experience surveys and reports, to gain further insights into the patient pathway for those diagnosed with NC.

From initial symptoms, through seeking advice to diagnostics and treatments – does current experience of neuroendocrine cancer care confirm the influential factors identified in previous cancer care reports?
Are there particular differences – and if so, what are these?

*Neuroendocrine tumours (NETs), neuroendocrine carcinomas (NECs), neuroendocrine neoplasms (NENs) and carcinoid tumours are collectively referred to as ‘neuroendocrine cancer’.

Read the NCUK Barriers Survey Report.